8-K filing — NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Filed: 2026-10-05 AccNo: 0001213900-26-106677 Size: 232 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
NeuroOne Medical Technologies Announces Southern California Distribution Agreement For OneRF Trigeminal Nerve Ablation System; No Minimum Purchase Commitments
NMTC stock has given up its prior gain. NeuroOne Medical Technologies shares were trading higher after the company announced it has completed three separate large-animal procedures using its next-generation StereoCED platform.